jump to the main content
jump to the bottom of the page

Contenido en español
Contingut en català
Current language Spanish

COLLABORATE El Meu Clínic

Contenido en español
Contingut en català
Current language Spanish

Gregori Casals

Research group

Translational research group in new therapeutic and diagnostic strategies in liver diseases Accredited researcher (R3A)

casals@clinic.cat 0000-0002-3271-1371

Follow it on:

The Researchgate of Gregori . This link opens in a new tab.

Featured publications

Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma

Authors:
Fernández-Varo, G; Perramón, M; Carvajal, S; Oró, D; Oller, L;

(...)

Navasa, M; Fuster, J; Garcia-Valdecasas, JC; Pavel, MC; Puntes, V.

Reference: Hepatology 2020.
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide.

Authors:
Casals, E; Gusta, MF; Puntes, V; Piella, J; Casals, G;

Jiménez, W.

Reference: Frontiers In Immunology 2017.
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display antiinflammatory properties in rats with liver fibrosis

Authors:
Oro, Denise; Yudina, Tetyana; Fernandez-Varo, Guillermo; Casals, Eudald; Reichenbach, Vedrana;

(...)

Gonzalez de la Presa, Bernardino; Sandalinas, Silvia; Carvajal, Silvia; Puntes, Victor; Jimenez, Wladimiro.

Reference: Journal Of Hepatology 2016.
Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes

Authors:
Casals, G; Ros, J; Morales-Ruiz, M; Jiménez, W; Sionis, A;

Davidson, MM.

Reference: American Journal Of Physiology-Heart And Circulatory Physiology 2009.

Featured Projects

THERANANO: Determining the therapeutic use in liver diseases of advanced antioxidant conjugates based on cerium oxide nanoparticles

Principal investigator: Gregori Casals Mercadal

Code: PI19/0074

Duration: 01/01/2020 - 31/12/2022
Evaluation of antioxidant and anti-inflammatory properties of cerium oxide nanoparticles as novel therapeutic strategy in hepatic steatosis.

Principal investigator: Gregori Casals Mercadal

Funder: Fondo de Investigación Sanitaria

Duration: 01/01/2016 - 01/01/2018
Cerium oxide nanoparticles as a new therapeutic tool for tissue regeneration in liver diseases

Principal investigator: Víctor Franco Puntes

Duration: 01/01/2013 - 01/01/2015
Basic and translational implications of the functional and molecular alterations of the hepatic endothelium in cirrhosis

Principal investigator: Manuel Morales Ruiz

Duration: 01/01/2011 - 01/01/2013
Pathophysiological role of activated liver endothelial cells in cirrhosis. Possible therapeutical implications

Principal investigator: Manuel Morales Ruiz

Duration: 01/01/2008 - 01/01/2010